Three-week course comparable to six-week treatment, researchers find WEDNESDAY, Nov. 4 (HealthDay News) -- "This concept of a shorter length of treatment is gaining acceptance," said Dr. Manjeet Chadha, associate chair of...
[read full story]
Women with early breast cancer can now benefit from less gruelling treatment, after researchers found giving high-dose radiation therapy in half the time could be just as effective as longer courses with more side-effects.
For the first time, researchers at Fred Hutchinson Cancer Research Center have reported the use of a radiolabeled antibody to deliver targeted doses of radiation, followed by a stem cell transplant, to successfully treat a...
Study Shows Positive Results With 3-Week Course of Treatment By Charlene Laino WebMD Health News Reviewed By Louise Chang, MD Nov. 4, 2009 (Chicago) -- "We cut the duration of radiation treatment in half," says study researcher...
For the first time, researchers at Fred Hutchinson Cancer Research Center have reported the use of a radiolabeled antibody to deliver targeted doses of radiation, followed by a stem cell transplant, to successfully treat a...
HealthDay Reporter WEDNESDAY, Nov. 4 (HealthDay News) -- "This concept of a shorter length of treatment is gaining acceptance," said Dr. Manjeet Chadha, associate chair of radiation oncology at Beth Israel Medical Center and...
Boost of Targeted Radiation May Keep Prostate Cancer at Bay, Study Suggests from coming back, a study of nearly 400 men suggests. "Importantly, there were no differences between the groups in terms of the urinary or bowel...
The use of targeting mechanisms makes existing anti-cancer methodologies, such as radiation or toxic chemicals, work far more effectively and inflict less harm upon the patient. Via EurekAlert! : researchers used "a...
For the first time, researchers at Fred Hutchinson Cancer Research Center have reported the use of a radiolabeled antibody to deliver targeted doses of radiation, followed by a stem cell transplant, to successfully treat a...
CHICAGO (MedPage Today) -- Prostate cancer patients had a reduced risk of biochemical failure if they were taking a statin during during radiation therapy, data from a retrospective cohort study showed.
CHICAGO, Nov. 2 /PRNewswire-USNewswire/ -- Short-term hormone therapy given prior to and during radiation treatment to medium-risk prostate cancer patients increases their chance of living longer, compared to those who receive...